
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CAMP market cap is 9.16M. The company's latest EPS is USD and P/E is N/A.
Quarter End | Sep 2024 |
---|---|
USD (US$) | |
Total Revenue | -10.13M |
Operating Income | -43.63M |
Net Income | -38.95M |
Year End December 30 2023 | 2023 |
---|---|
USD (US$) | |
Total Revenue | 19.15M |
Operating Income | 3.38M |
Net Income | 2.48M |
Quarter End | Sep 2024 |
---|---|
USD (US$) | |
Total Assets | 21.36M |
Total Liabilities | 18.19M |
Total Equity | -158.98M |
Year End December 30 2023 | 2023 |
---|---|
USD (US$) | |
Total Assets | 11.5M |
Total Liabilities | 5.41M |
Total Equity | 6.09M |
Market Cap | 9.16M |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 1.65M |
Average Volume (1 week) | 27.01k |
Average Volume (1 Month) | 24.77k |
52 Week Change | 72.36% |
52 Week High | 12.30 |
52 Week Low | 0.3901 |
Spread (Intraday) | 0.63 (10.59%) |
Company Name | CAMP4 Therapeutics Corporation |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.camp4tx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions